Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CAD 271.10 billion. The enterprise value is 306.12 billion.

Market Cap	271.10B
Enterprise Value	306.12B

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.51B

Valuation Ratios

The trailing PE ratio is 10.82 and the forward PE ratio is 8.82.

PE Ratio	10.82
Forward PE	8.82
PS Ratio	2.95
PB Ratio	3.90
P/TBV Ratio	17.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.70, with an EV/FCF ratio of 12.50.

EV / Earnings	12.22
EV / Sales	3.51
EV / EBITDA	7.70
EV / EBIT	9.19
EV / FCF	12.50

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio	1.41
Quick Ratio	0.83
Debt / Equity	0.72
Debt / EBITDA	1.20
Debt / FCF	2.04
Interest Coverage	19.06

Financial Efficiency

Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.

Return on Equity (ROE)	39.29%
Return on Assets (ROA)	13.81%
Return on Invested Capital (ROIC)	19.33%
Return on Capital Employed (ROCE)	27.14%
Revenue Per Employee	1.24M
Profits Per Employee	338,632
Employee Count	75,000
Asset Turnover	0.58
Inventory Turnover	2.31

Taxes

In the past 12 months, Merck & Co. has paid 3.91 billion in taxes.

Income Tax	3.91B
Effective Tax Rate	13.48%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	18.15
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.90
Average Volume (20 Days)	9,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.15

Income Statement

In the last 12 months, Merck & Co. had revenue of CAD 91.88 billion and earned 25.06 billion in profits. Earnings per share was 9.89.

Revenue	91.88B
Gross Profit	70.81B
Operating Income	35.09B
Pretax Income	28.99B
Net Income	25.06B
EBITDA	41.39B
EBIT	35.09B
Earnings Per Share (EPS)	9.89

Full Income Statement

Balance Sheet

The company has 13.26 billion in cash and 50.08 billion in debt, giving a net cash position of -36.82 billion.

Cash & Cash Equivalents	13.26B
Total Debt	50.08B
Net Cash	-36.82B
Net Cash Per Share	n/a
Equity (Book Value)	69.57B
Book Value Per Share	27.61
Working Capital	14.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 30.01 billion and capital expenditures -5.52 billion, giving a free cash flow of 24.49 billion.

Operating Cash Flow	30.01B
Capital Expenditures	-5.52B
Free Cash Flow	24.49B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.

Gross Margin	77.07%
Operating Margin	38.19%
Pretax Margin	31.55%
Profit Margin	27.27%
EBITDA Margin	45.05%
EBIT Margin	38.19%
FCF Margin	26.66%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	45.54%
Buyback Yield	0.30%
Shareholder Yield	n/a
Earnings Yield	9.24%
FCF Yield	9.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.

Altman Z-Score	4.7
Piotroski F-Score	7